Estrogen-induced mu-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats

J Neurosci. 2004 Jan 28;24(4):947-55. doi: 10.1523/JNEUROSCI.1366-03.2004.

Abstract

The endogenous peptides beta-endorphin (beta-END) and neuropeptide Y (NPY) have been implicated in regulating sexual receptivity. Both beta-END and NPY systems are activated by estrogen and inhibit female sexual receptivity. The initial estrogen-induced sexual nonreceptivity is correlated with the activation and internalization of mu-opioid receptors (MORs), in the medial preoptic nucleus (MPN). Progesterone reverses the estrogen-induced activation/internalization of MOR and induces the sexual receptive behavior lordosis. To determine whether NPY and endogenous opioids interact, we tested the hypothesis that estrogen-induced MOR activation is mediated through NPY-Y1 receptor (Y1R) activation. Retrograde tract tracing demonstrated Y1Ron beta-END neurons that projected to the MPN. Sex steroid modulation of MOR in the MPN acts through NPY and the Y1R. Estradiol administration or intracerebroventricular injection of NPY activated/internalized Y1R in the arcuate nucleus and MOR in the MPN of ovariectomized (OVX) rats. Moreover, the selective Y1R agonist [Leu31, Pro34]-Neuropeptide Y (LPNY) internalized MOR in the MPN of OVX rats. The Y1R antagonist (Cys31, Nva34)-Neuropeptide Y (27-36)2 prevented estrogen-induced Y1R and MOR activation/internalization. NPY reversed the progesterone blockade of estradiol-induced Y1R and MOR internalization in the arcuate nucleus and MPN, respectively. Behaviorally, LPNY inhibited estrogen plus progesterone-induced lordosis, and the MOR-selective antagonist D-Phe-Cys-Tyr-d-Trp-Orn-Thr-Pen-Thr amide reversed LPNY-induced inhibition of lordosis. These results suggest that a sequential sex steroid activation of NPY and MOR circuits regulates sexual receptivity.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arcuate Nucleus of Hypothalamus / cytology
  • Arcuate Nucleus of Hypothalamus / metabolism*
  • Estradiol / pharmacology
  • Estrogens / pharmacology*
  • Female
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuropeptide Y / analogs & derivatives*
  • Neuropeptide Y / pharmacology
  • Ovariectomy
  • Posture / physiology
  • Preoptic Area / cytology
  • Preoptic Area / drug effects
  • Preoptic Area / metabolism*
  • Progesterone / pharmacology
  • Rats
  • Rats, Long-Evans
  • Receptors, Neuropeptide Y / agonists
  • Receptors, Neuropeptide Y / metabolism*
  • Receptors, Opioid, mu / drug effects
  • Receptors, Opioid, mu / metabolism*
  • Sexual Behavior, Animal / drug effects
  • Sexual Behavior, Animal / physiology
  • Somatostatin / analogs & derivatives*
  • Somatostatin / pharmacology

Substances

  • Estrogens
  • Neuropeptide Y
  • Receptors, Neuropeptide Y
  • Receptors, Opioid, mu
  • neuropeptide Y-Y1 receptor
  • phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide
  • neuropeptide Y, Leu(31)-Pro(34)-
  • Progesterone
  • Estradiol
  • Somatostatin